Men’s Preventive Care

Prostate, testicular, CV screening, skin checks, and healthy aging basics.

  • 2 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Men’s Preventive Care


theargus.co.uk > news > 26614042.worthing-lions-test-1-206-men-prostate-health-event

Worthing Lions test 1,206 men at prostate health event

8+ hour, 34+ min ago   (219+ words) A record-breaking 1,206 men were tested in a single day during a community prostate health event. The PSA (prostate-specific antigen) testing, run by Worthing Lions in partnership with the Prostate Cancer Support Organisation (PCaSO), took place on September 19 at the Charmandean…...


thailand-business-news.com-business-news.com

SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

8+ hour, 33+ min ago   (428+ words) Thailand Business News SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology BOSTON, Oct. 8, 2026 /PRNewswire/ — SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) today announce a collaboration to advance new prostate cancer-specific…...


springermedicine.com > impact-of-different-suvmax-thresholds-on-diagnostic-accuracy-of- > 53826636

Impact of different SUVmax thresholds on diagnostic accuracy of [68Ga]Ga-PSMA PET/CT versus 99mTc-MDP planar bone scintigraphy in prostate cancer

13+ hour, 58+ min ago   (148+ words) Unlock your free and exclusive access to the latest news and expert interviews from the 62nd Annual Meeting of the European Association for the Study of Diabetes. Projected result for your current search:: 0 1.25 AMA PRA Category 1 Credits™ How can your team…...


oncodaily.com > voices > emmanuel-mduma-604046

Emmanuel Mduma Discussed GnRH Agonists and Antagonists in Prostate Cancer Treatment at TICC26

8+ hour, 35+ min ago   (135+ words) Oncodaily Emmanuel Mduma Discussed GnRH Agonists and Antagonists in Prostate Cancer Treatment at TICC26 Emmanuel Mduma, Clinical Oncology Specialist at Rabininsia Memorial Hospital, Lecturer at Rabininsia University, shared on LinkedIn: “Meaningful experience at TICC26 – The 4th Tanzania International Cancer Conference. I was privileged…...


urotoday.com > conference-highlights > eau-2026 > eau-2026-prostate-cancer > 167469-eau-2026-how-to-optimize-germline-and-somatic-testing-in-prostate-cancer.html

EAU 2026: How to Optimize Germline and Somatic Testing in Prostate Cancer?

8+ hour, 54+ min ago   (180+ words) HRR mutations are commonly of germline origin, with several real world studies suggesting a 23-44% probability of an HRR alteration to be of germline origin:1 The following summarizes recommendations for germline and somatic testing in localized and metastatic disease: Tumor only…...


urotoday.com > video-lectures > pcf-va-medical-education-program > video > 5904-dna-repair-deficiency-and-the-rationale-for-germline-testing-in-prostate-cancer-bruce-montgomery.html

DNA Repair Deficiency and the Rationale for Germline Testing in Prostate Cancer - Bruce Montgomery

9+ hour, 1+ min ago   (1753+ words) Bruce Montgomery reviews germline and somatic testing gaps in VA prostate cancer care. Dr. Montgomery reports VA somatic sequencing rates approach 80% in POPCaP sites, far outpacing the roughly 40% community rate, but germline testing uptake remains only 10% to 30% nationally despite universal…...


bioengineer.org > a-single-trna-molecule-controls-whether-prostate-cancer-stays-vulnerable-to-therapy

A Single tRNA Molecule Controls Whether Prostate Cancer Stays Vulnerable to Therapy

7+ hour, 33+ min ago   (764+ words) A new Nature study shows that the dosage of a single transfer RNA, tRNA1Arg(UCU), acts as a reversible molecular switch controlling lineage dependency, therapy resistance and survival outcomes in prostate cancer....


curetoday.com > view > why-psa-monitoring-matters-after-a-prostate-cancer-diagnosis

Why PSA Monitoring Matters After a Prostate Cancer Diagnosis

11+ hour, 28+ min ago   (550+ words) Prostate cancer grows slowly, and while 50% of men on active surveillance eventually need treatment, waiting can mean years without side effects. Men newly diagnosed with prostate cancer face a range of treatment options, from robotic surgery and focal therapy to…...


bioengineer.org > dopamine-agonist-pills-shrink-prolactin-tumors-in-men-but-hormones-and-size-tell-different-stories

Dopamine Agonist Pills Shrink Prolactin Tumors in Men, but Hormones and Size Tell Different Stories

8+ hour, 7+ min ago   (648+ words) A retrospective study of 108 Chinese men with prolactinoma shows that dopamine agonist therapy achieves strong biochemical and tumor control, but a new integrated, time-dependent framework reveals that prolactin, tumor size, and testosterone responses often diverge....


urotoday.com > conference-highlights > asco-gu-2026 > asco-gu-2026-prostate-cancer > 166993-asco-gu-2026-physician-perspectives-on-the-implementability-of-a-cardiovascular-risk-score-for-prostate-cancer-a-prism-guided-evaluation.html

ASCO GU 2026: Physician Perspectives on the Implementability of a Cardiovascular Risk Score for Prostate Cancer: A PRISM-guided Evaluation.

12+ hour, 40+ min ago   (250+ words) ASCO GU 2026, Prostate Cancer, Cardiovascular Risk Score, PRISM score, Implementability of a Cardiovascular Risk Score for Prostate Cancer. (UroToday.com) The 2026 ASCO GU Annual Symposium featured a prostate cancer and urothelial carcinoma poster session Harikrishnan Kunhiraman presented results from a…...